Ana Cristina Souza Bombaça

Dr. Ana Cristina Souza Bombaça


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ABAna Cristina Souza Bombaça
Ana Cristina Souza Bombaça
PVPaula G. Viana
Paula G. Viana
ASAugusto C.C. Santos
Augusto C.C. Santos
TSThaissa L. Silva
Thaissa L. Silva
ARAline Beatriz M. Rodrigues
Aline Beatriz M. Rodrigues
Rubem Menna-BarretoRubem Menna-Barreto
Rubem Menna-Barreto

7 January 2019 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
GDGleiston Dias
Gleiston Dias
TNTamires A. Do Nascimento
Tamires A. Do Nascimento
AAAndresa K. A. de Almeida
Andresa K. A. de Almeida
ABAna Cristina Souza Bombaça
Ana Cristina Souza Bombaça
RMRubem F. S. Menna‐Barreto
Rubem F. S. Menna‐Barreto
LALutz Ackermann
Lutz Ackermann

1 August 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MCMARIANA FILOMENA DO CARMO CARDOSO
MARIANA FILOMENA DO CARMO CARDOSO
KSKelly Salomão
Kelly Salomão
ABAna Cristina Souza Bombaça
Ana Cristina Souza Bombaça
David da RochaDavid da Rocha
David da Rocha
FSFernando de C. da Silva
Fernando de C. da Silva
Vitor ferreiraVitor ferreira
Vitor ferreira

14 June 2018 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
RCRenato L. de Carvalho
Renato L. de Carvalho
GJGuilherme A. M. Jardim
Guilherme A. M. Jardim
ASAugusto C. C. Santos
Augusto C. C. Santos
MAMaria H. Araujo
Maria H. Araujo
WOWillian Oliveira
Willian Oliveira
EJEufrânio N. Da Silva Júnior
Eufrânio N. Da Silva Júnior

28 October 2018 in Molecules
Verified
Journal Article
Open access
PDF file
ABAna Cristina Souza Bombaça
Ana Cristina Souza Bombaça
DDDaniela Von Dossow
Daniela Von Dossow
JBJuliana Magalhães Chaves Barbosa
Juliana Magalhães Chaves Barbosa
Cristian PazCristian Paz
Cristian Paz
CPCristian Paz
Cristian Paz
Rubem Menna-BarretoRubem Menna-Barreto
Rubem Menna-Barreto
Chagas disease is a neglected tropical disease that is caused by the protozoan Trypanosoma cruzi and represents a serious health problem, especially in Latin America. The clinical treatment of Chagas disease is based on two nitroderivatives that present severe side effects and important limitations. In folk medicine, natural products, including sesquiterpenoids, have been employed for the treatment of different parasitic diseases. In this study, the trypanocidal activity of compounds isolated from the Chilean plants Drimys winteri, Podanthus mitiqui and Maytenus boaria on three T. cruzi evolutive forms (epimastigote, trypomastigote and amastigote) was evaluated. Total extracts and seven isolated sesquiterpenoids were assayed on trypomastigotes and epimastigotes. Polygodial (Pgd) from D. winteri, total extract from P. mitiqui (PmTE) and the germacrane erioflorin (Efr) from P. mitiqui were the most bioactive substances. Pgd, Efr and PmTE also presented strong effects on intracellular amastigotes and low host toxicity. Many ultrastructural effects of these substances, including reservosome disruption, cytosolic vacuolization, autophagic phenotype and mitochondrial swelling (in the case of Pgd), were observed. Flow cytometric analysis demonstrated a reduction in mitochondrial membrane potential in treated epimastigotes and an increase in ROS production and high plasma membrane permeability after treatment with Pgd. The promising trypanocidal activity of these natural sesquiterpenoids may be a good starting point for the development of alternative treatmentsforChagas disease.

17 August 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
NPNathalia Pinho
Nathalia Pinho
JWJacek R. Wiśniewski
Jacek R. Wiśniewski
GLGeovane Dias Lopes
Geovane Dias Lopes
LVLeonardo Saboia Vahia
Leonardo Saboia Vahia
ABAna Cristina Souza Bombaça
Ana Cristina Souza Bombaça
PCPatricia Cuervo
Patricia Cuervo
Leishmania species are responsible for a broad spectrum of diseases, denominated Leishmaniasis, affecting over 12 million people worldwide. During the last decade, there have been impressive efforts for sequencing the genome of most of the pathogenic Leishmania spp. as well as hundreds of strains, but large-scale proteomics analyses did not follow these achievements and the Leishmania proteome remained mostly uncharacterized. Here, we report a comprehensive comparative study of the proteomes of strains representing L. braziliensis, L. panamensis and L. guyanensis species. Proteins extracted by SDS-mediated lysis were processed following the multi-enzyme digestion-filter aided sample preparation (FASP) procedure and analysed by high accuracy mass spectrometry. “Total Protein Approach” and “Proteomic Ruler” were applied for absolute quantification of proteins. Principal component analysis demonstrated very high reproducibility among biological replicates and a very clear differentiation of the three species. Our dataset comprises near 7000 proteins, representing the most complete Leishmania proteome yet known, and provides a comprehensive quantitative picture of the proteomes of the three species in terms of protein concentration and copy numbers. Analysis of the abundance of proteins from the major energy metabolic processes allow us to highlight remarkably differences among the species and suggest that these parasites depend on distinct energy substrates to obtain ATP. Whereas L. braziliensis relies the more on glycolysis, L. panamensis and L. guyanensis seem to depend mainly on mitochondrial respiration. These results were confirmed by biochemical assays showing opposite profiles for glucose uptake and O2 consumption in these species. In addition, we provide quantitative data about different membrane proteins, transporters, and lipids, all of which contribute for significant species-specific differences and provide rich substrate for explore new molecules for diagnosing purposes. Data are available via ProteomeXchange with identifier PXD017696. Leishmania braziliensis, L. panamensis, and L. guyanensis are responsible for most of the cases of tegumentary leishmaniasis (TL) in the Americas. These species are associated with a variety of clinical manifestations of TL ranging from self-healing localized cutaneous lesions to disseminated and mucocutaneous presentations that may result in severe oropharyngeal mutilation. Here, we report a comprehensive quantitative comparison of the proteome of those species. Assessment of absolute titers of ~7000 proteins revealed a very clear differentiation among them. Significant differences in energy metabolism, membrane proteins, transporters, and lipids are contributing for species-specific traits and provide rich substrate for exploring new molecules for diagnosing purposes.